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Cancer is the second most common cause of death in the U.S. and accounts for 
one of every four deaths (American Cancer Society, Surveillance Research, 2008).  In 
2007, the overall estimated cost of cancer according to the National Institutes of Health 
was $219.2 billion (American Cancer Society, Surveillance Research, 2008).   
Breast cancer is the most frequently diagnosed cancer in women, excluding skin 
cancers, and ranks second as cause of cancer death in women (American Cancer Society, 
Surveillance Research, 2008).  More than 200,000 new breast cancer cases are diagnos  
yearly with more than 40,000 women dying annually from the disease (Lopez-Otin et al., 
1998).  There has been a slight decline in breast cancer incidence beginning around 2000 
which may be a result of decreased screening and decreased use of hormone replacement 
therapy.  Death rates in women from breast cancer have also decreased since 1990.  This 
is said to be a result of progress in earlier detection and improved treatment (Aerican 
Cancer Society, Surveillance Research, 2008).  
 2
Although the pathogenesis of breast cancer is still not well understood, age and 
race are known to play an important role in determining breast cancer risk (Smigal et al., 
2006). There have been certain factors that have had long-standing implications in breat 
cancer such as the use of steroid hormones (Lopez-Otin et al., 1998). Breast cancer 
incidence can be attributed to age, gender, genetic predisposition, and ethnicity 
(American Cancer Society, Surveillance Research, 2008).  Hormonal effects and 
environmental factors also appear to play a major role in the development and 
progression of the disease (Tsubura et al., 2005, Colditz etal., 1995, Adami et al., 1998).    
 In the pathogenesis and progression of breast cancer, there are various courses of 
treatment, such as radiation, chemotherapy, and surgery which have varying degrees of 
side effects.  Many side effects of conventional therapies include loss of appetite, w ight, 
loss of hair, nausea and vomiting just to name a few.  Tamoxifen, a non-steroidal anti-
estrogen, is a pharmacological option commonly used to treat all stages of brast cancer.  
The drug was first approved in 1973 for the treatment of breast cancer as a 
chemopreventive agent.  Due to a known link between estrogen and the initiation and 
growth of some breast cancers, tamoxifen was also tested as a potential treatment for 
advanced breast cancer in postmenopausal women (Smigal et al., 2006, Jordan et al., 
2003).   
 Today, chemoprevention agents are the most promising non-toxic option for 
reducing cancer incidence by possibly exerting their effects either by blocking or 
metabolizing carcinogens or by inhibiting tumor cell growth.  They have recently been 
used in cancer treatment in combination with conventional chemotherapeutics or 
radiotherapy (Sarkar et al., 2007). 
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 Dietary factors are widely believed to play an important role in determining the 
risk of many cancers, including breast cancer.  A diet rich in fruits and vegetables is rich 
in antioxidants which have been shown to have beneficial roles in cancer prevention 
(Lopez-Otin et al., 1998).  Research supports the role of reactive oxygen species in 
cancer and that dietary antioxidants as well as endogenous antioxidants neutralize or trap 
reactive oxygen species, thereby acting as cancer preventive agents (Borek, 2004 A,  
Steinmetz et al., 1996).  Dietary modifications such as increasing fruit and vegetabl  
intake are favored over pharmacological options due to the costs associated with 
pharmaceuticals and the side effects from conventional therapies. 
A fruit that may play an important role in the inhibition and prevention of breast 
cancer are grapes which are high in polyphenols.  Phenolic compounds found in grapes 
such as resveratrol have been shown to act as antioxidants which can scavenge free 
radicals and delay or prevent cancer development (Tsubura et al., 2005, Jang et al., 1997, 
Nakagawa et al., 2001, Joe et al., 2002, Kim, et al., 2004).  The antioxidant activity of red 
grape proanthocyanidins has been demonstrated by the inhibition of aromatase enzyme 
activity and growth of cancer cells, and preventing disease in various animal models (Eng 
et al., 2003, Agarwal et al., 2000, Zhao et al., 1999).   
Polyphenolic content of grapes vary by variety and growth conditions (Shi et al., 
2003). To our knowledge, there is limited research on grape varieties grown in 
Oklahoma. Although there have been several studies that have investigated the anti-
cancer properties of resveratrol and grape seed extract (Singletary, Jung, and Giusti, 
2007, Mantena et al., 2006, Kim, Hall, and Smith et al., 2004, Laux et al., 2004, Pozo-
Guisado et al., 2005), to our knowledge there is no study conducted of Rubaiyat, an 
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Oklahoma red grape variety.  Moreover, the Rubaiyat grape variety was chosen due to its 
relatively high polyphenol content.  Research on the disease prevention properties of 
Oklahoma grapes will help Oklahoma grape growers, a relatively new and expanding 
industry, promote their product.  Studying the anti-proliferative properties of an 
Oklahoma grape variety will help promote the importance of grape growing in the state.   
The hypothesis of this study is that the polyphenol-rich grape extract of Rubaiyat 
grapes possess anti-proliferative properties similar to that of resveratrol.  The specific 
aim of this study is to compare the effect of Rubaiyat polyphenolic-rich grape extract to 
that of resveratrol in (a) inhibiting cell proliferation and (b) inducing apoptosis in human 
breast cancer MCF-7 cell line. Moreover, we will try to begin to explore the anti-
proliferative mechanism of action of Rubaiyat polyphenolic-rich grape extract by 
investigating the relative mRNA gene expression of apoptotic genes, Bax and Bcl-2.    
The study has several limitations: 
(a) Our study utilized an in vitro system which behaves differently than in vivo systems.  
Animal and human studies are needed to confirm the findings of our study. 
 (b) The use of phenolic-rich grape extract has different effects compared to that of whole 
grapes. Although Rubaiyat grape variety is high in polyphenol content, there are other 
components of grapes that may promote the inhibition of cellular proliferation and 
induction of apoptosis.  Isolating the phenolic-rich grape extract may have eliminated 
other compounds that may work together with polyphenols to inhibit breast cancer.  
Other compounds in Rubaiyat grapes alongside the polyphenols may present other 
potential anti-cancer effects.  Although pure grape extracts can give definitiv  results in 
vitro or in animal studies, research on whole grapes is also as important as humans 
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generally consume whole grapes.  Human studies are warranted for the determination of 
the effects of the whole grape on breast cancer inhibition and prevention.   
(c)  We did not attempt to isolate phenolic compounds from the different parts of grapes 
(pulp, seed, or skin).  Zhao et al., (1999) have demonstrated different amounts and kinds 
of polyphenols in these different parts of grapes.  During extraction of polyphenols, 





REVIEW OF LITERATURE 
 
I. Breast Cancer 
A. Prevalence 
According to the American Cancer Society (ACS), breast cancer accounts for 
more than 1 in 4 cancers diagnosed in U.S. women (ACS, Breast Cancer Facts & Figures, 
2007). However, the incidence rates for breast cancer decreased by 3.5% per year
between 2001-2004 and the mortality rate decreased by 2.2% annually from 1990-2004 
(ACS, Breast Cancer Facts & Figures, 2007). This decline, while more prevalent amo g 
the younger age groups, has been attributed to improvements in treatment and early 
detection (ACS, Breast Cancer Facts & Figures, 2007).   
The incidence and death rates for breast cancer tend to increase with age; 95% of 
new cases and 97% of deaths occurred in women 40 and older during 2000-2004 (ACS, 
Breast Cancer Facts & Figures, 2007).  During these same years, women 20-24 years of 
age had the lowest rate of incidence (1.4 cases per 100,000 women) while 464.8 cases per 
100,000 were observed in women aged 75-79 years.  In the years 2000-2004, the median 
age at the time of diagnosis of breast cancer was 61 years old (ACS, Breast Cancer Facts 
& Figures, 2007).  
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In addition to age, other known risk factors for breast cancer include gender, 
genetic predisposition, and ethnicity.  Breast cancer differs among ethnicities with 
highest incidence in White women followed by African Americans, Asian 
Americans/Pacific Islanders, Hispanics/Latinas, and American Indians/Alaska Natives 
(Jemal et al., 2006, Smigal et al., 2006).  Whites and African American women are two 
populations more likely to die from breast cancer at every age, however, death rat s are 
lower among white women than African American women (ACS, 2007).  However, from 
1992-2004, American Indians/Alaska Natives showed decreased incidence while there 
was no significant change among Asian Americans/Pacific Islanders or Hi panics/Latinas 
(ACS, 2007).   
Epidemiological studies show that breast cancer is 5-fold higher in Western 
countries than in some Asian countries (Adami et al., 1998).  The higher breast cancer 
incidence rate among Whites is thought to reflect a combination of factors that affect 
diagnosis, such as a more frequent mammography in White women, and factors that 
affect disease risk such as later age at first birth and greater use of hormone replacement 
therapy among Whites than African American women (Jemal et al., 2006, Smigal et al., 
2006).  
 
B. Etiology and  pathogenesis 
The etiology of human breast cancer is largely unknown. Several factors have 
been suggested to play a role in the development and progression of breast cancer. These 
factors include age, gender, genetic susceptibility, ethnicity, chronic inflammation, 
hormonal effects, and environmental factors such as alcohol consumption and smoking 
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(Smigal et al., 2006, Valko et al., 2004, Colditz et al., 1995). However, known genetic 
risk factors are only present in a small number of breast cancer cases.  Human breast 
cancer occurs with 100-fold greater incidence in females than in males (Tsubura et al., 
2005, Colditz and Frazier, 1995, Adami et al., 1998), who are rarely affected which is 
suggested to be due to androgenic dominance over estrogens which keeps breast 
underdeveloped throughout life (Lopez-Otin et al., 1998).  Early age of menarche, late 
age of menopause and late age of full-term pregnancy are associated with increased 
breast cancer risk.  Such associations are suggested to be due to estrogens which play an 
important role in the etiology of breast cancer (Tsubura et al., 2005).  
Generation of reactive oxygen species (ROS) have also been implicated in the 
development of many chronic diseases including breast cancer. Many cellular processes 
of the body produce ROS such as through leakage from the mitochondria and electron 
transport chain, two very important biological processes for normal functioning of the
body (Valko et al., 2004).  At normal concentrations, ROS can act as a defense 
mechanism against foreign agents to rid the body of toxic substances; however, it can 
also act as disease causing agents if present in excess amounts.  It has been estimated that 
anywhere from 10,000-20,000 free radicals attack each cell of the body every day and 
varies from person to person (Valko et al., 2004).  ROS can cause genetic mutations and 
chromosomal rearrangements that can lead to cancer.  Once cancer occurs, oxidative 
stress increases the progression of the disease (Valko et al., 2004, Nishikawa et al., 2008). 
Endogenous antioxidants decrease with age, as does DNA repair capacity; exposur  to 
radiation and to anticancer drugs that produce free radicals further decreases c llular and 
blood levels of antioxidants (Borek, 2004 A, Borek, 2004 B).  
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Different metabolic pathways are affected during carcinogenesis. Amundadottir 
and Leder (1998) analyzed the activation and requirement for signal transduction 
pathways in mammary gland tumors initiated by different oncogenes.  Transgenic mice 
over-expressing oncogenes that encode for specific growth factors, growth factor 
receptors, and transcription factors involved in carcinogenesis showed that two signal 
transduction pathways are activated in an oncogenic specific manner in mammary tu ors 
and their derived cell lines.  These pathways include the Erk/MAP kinase pathway in neu 
and v-Ha-ras initiated mammary tumors and PI 3-kinase activity in TGFα, 
heregulin/NDF and neu initiated tumor cell lines.  This specificity suggests that 
oncogenes might use different signaling pathways in order to transform mammary 
epithelial cells (Amundadottir and Leder, 1998). 
In an in vitro study of human MCF-7 and T47D breast cancer cell lines, Gomez 
and colleagues (2007) showed that spliced human X-box binding protein-1 (XBP1 (S)), is 
stably over expressed in these cell lines and does not require estrogen for cell gr wth and 
is resistant to certain breast cancer chemotherapy drugs.  It was also found that XBP1 (S) 
overexpression alters the expression of several apoptotic and cell cycle genes and 
promotes cell survival.  The antiapoptotis gene, Bcl2, is one of the several up-regulated 
genes by XBP1 (S) in MCF-7 cells (Gomez et al., 2007).  
In another in vivo study, Liu et al. (2007) investigated the role of erbB3 in erbB2 
RTK activity and erbB2-mediated tumorigenesis (proteins involved in tumorigenesis) and 
tamoxifen resistance.  The results suggest that kinase activity of erbB2 phosphorylates 
erbB3 and leads to the subsequent activation of downstream signaling of other kinases,
for example PI-3K/Akt.  The downregulation of erbB3 disrupts heterodimer formation 
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and results in the inactivation of downstream signaling.  The downregulation of these 
kinases may result in less resistance to tamoxifen by breast cancer cells (Liu et al., 2007).   
Investigators have researched and proposed many signal transduction pathways 
and cascades involved in the development and progression of breast cancer.  There have 
been studies conducted on chemotherapy resistant breast cancers.  This is a vast feld of 
research that deserves and continues to receive lots of attention.  The possibilitie  of 
preventing and treating the often times fatal disease as well as reducing chemotherapy 
resistance is of great importance to society.   
Jourdain and Martinou (2009) report that the Bcl-2 family of proteins is pro-
apoptotic proteins which permeabilize the mitochondria during apoptosis by integrating 
and conveying death signals to the mitochondria in order to cause the release of other 
proteins and enzymes to continue with the apoptotic process.  Their actions are put into 
motion due to their hydrophobic residues which make them capable of attaching to the 
membrane of the mitochondria to induce the permeabilization process.  Bcl-2 (B-cell
lymphoma 2) is an anti-apoptotic protein whereas Bax is a pro-apoptotic protein. There 
are three domains that this family of proteins contains, BH1, 2, and 3.  The Bcl-2 family’s 
mechanism of action is proposed to be the neutralization of pro-apoptotic BH3-only 
proteins and consequently inhibit their effects on Bax/Bak activity and mitochondrial 
outer-membrane permeabilization.  Conformational changes of Bax and multimer 
formation with other Bcl-2 family members allow activation and release of other
apoptotic proteins from the same family (Tsujimoto, 2003).  These proteins act closely
together signaling one another in a cascade to promote the apoptosis process (Jourdain 
and Martinou, 2009, Tsujimoto, 2003). 
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C. Treatment options 
 Borek (2004) reports that almost all anti-cancer drugs work by affecting DNA 
synthesis; they do not kill resting cells unless those cells divide soon after exposure to the 
drug.  Consequently, the efficacy of anti-cancer drugs used in chemotherapy is limited by 
the fraction of actively dividing cells.  Most anti-cancer drugs do not rely on ROS 
generation for aid in anti-cancer activity, although a few produce free radicals that play a 
role in treatment such as bleomycin, which produces superoxide radicals.  Other anti-
cancer drugs include doxorubicin, cisplatin, and bleomycin.  Bleomycin is more toxic to 
oxygenated cells, similar to x-rays and γ-rays, while doxorubicin is preferentially toxic to 
hypoxic cells (Borek, 2004 A).   
The potential effect of antioxidants in enhancing efficacy of chemotherapy 
treatment depends on the type of drug in use (Borek, 2004 A).  Antioxidant protection of 
normal cells would occur, in principle, in all treatments even when the mechanism is 
independent of free radical action.  Antioxidants help maintain the integrity of normal 
tissues and protect them from such damaging effects (Borek, 2004 A).  
 According toYoon et al., (2007) in cancer treatment, some chemotherapeutic 
drugs that induce apoptosis lose their pro-apoptotic activities because they activate 
nuclear factor κB (NF-κB), so in order to prevent this from occurring, the inhibition of 
this transcription factor can restore the mechanisms of action of chemotherapeutic agents 
to induce apoptosis therefore inhibiting cancer cell viability and proliferation.  NF-κB is a 
transcription factor that regulates inflammation, immunity, apoptosis, cell proliferation 
and differentiation.  NF-κB is normally inactive by being bound to an inhibitory protein 
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(IκB-α) in the cytoplasm.  However, numerous extracellular stimuli including bacteria, 
viruses, inflammatory cytokines, growth factors, unltraviolet, and oxidative stress cause 
phosphorylation of the inhibitory protein IκB-α by IκB kinase (IKK). This causes the 
ubiquitination and degradation of IκB-α by proteasome to release NF-κB.  The released 
NF-κB migrates into the nucleus to bind DNA to activate the transcription of 
inflammatory and other target genes including cyclooxygenase-2 (COX-2), inducible 
nitric oxide synthase (iNOS), cyclin D1, and Bcl-2.  Activation of NF-κB induces cancer 
cell proliferation which brings chemo-resistance to cancer cells (Yoon and Liu, 2007).   
 Another treatment option in cancer is radiotherapy which uses mostly x-rays and 
γ-rays and to a lesser extent heavy particle radiation such as protons and neutrons (Borek, 
2004 A).  Radiation may be classified as directly or indirectly ionizing.  When any form 
of radiation is absorbed in tissues, there is a possibility that it may interact directly with 
cellular targets.  In the direct action, which is dominant when neutrons or protons are 
considered, the target atoms such as DNA, are directly ionized or excited, initiating 
events that lead to biological changes.  Alternatively, radiation may damage cells by 
indirect action.  In this mode of action, which is dominant in treatment with x-rays and γ-
rays, radiation interacts with cellular atoms or molecules to produce free radicals that 
diffuse far enough to reach and damage critical targets such as DNA.  About two thirds f 
x-ray and γ-ray damage is caused by free radicals that kill tumor cells but threaten the 
integrity and survival of surrounding normal cells.  Radiation induces mitotic cell death 
in dividing cells and activates pathways that lead to cell death by apoptosis in interphase 
cells and differentiated cells.  The development of cancer produces oxidative stress that 
increases with disease progression; levels of antioxidants further decrease in re ponse to 
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treatment, and therapeutic doses of radiation deplete α-tocopherol in normal cells, 
increasing their risk of damage (Borek, 2004 A).   
  
II. Breast Cancer and the Diet  
 It has been demonstrated that the diet plays a large role in the development of 
breast cancer.  Some of the studies investigating the relationship of diet and breast cancer 
are discussed below.  A prospective cohort study, also called the Nurses’ Health Study II, 
demonstrated that women with higher red meat consumption during high school had 
elevated risk of breast cancer whereas adult red meat consumption was not significantly 
associated with breast cancer (Linos et al., 2008).  The researchers also investigated 
different types of red meat and number of servings per day in relation to breast cancer 
and found that while greater intakes were associated with increased risk, this was not 
statistically significant (Linos et al., 2008).   
The 4-Corners study, a population-based case-control study of breast cancer,  
determined that there are no significant or consistent associations in the dietary intake of 
carotenoids, retinols, vitamin C and tocopherols and breast cancer incidence in Hispanic, 
American Indian, and non-Hispanic white women aged 25-79 years in Arizona, 
Colorado, New Mexico, or Utah (Wang, et al., 2008).  
The Malmo Diet and Cancer, a population-based cohort of 28,098 individuals 
living in Malmo, investigated the relationship of diet (particular fiber and energy) and 
incidence of breast cancer.   Sonestedt and colleagues (2008) determined that the mean 
intake of plant foods did not significantly differ between cases and non-cases of breast 
tumor incidence.  The highest quintile of fiber intake was not significantly associ ted 
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with a decrease in the risk of breast cancer whereas the highest quartile of high-fiber 
bread intake was significantly associated with a 25% decrease in risk when compared to 
the lowest quintile.  Overall, the study concluded that the intake of different plant foods 
may be differently associated with the risk of breast cancer (Sonestedt et al., 2008).   
 A case-control study of the relationship of diet and breast cancer risk found a 
strong protective effect associated with usual intake of vegetables and a less strong 
association with fruit intake (Freudenheim et al., 1996).  Reductions in risk were also 
associated with vitamin C, α-tocopherol, folic acid, α-carotene, β-carotene, lutein + 
zeaxanthin, and fiber from vegetables and fruits.  The investigators concluded that 
vegetables appear to exert a protective effect independent of vitamin C, α-tocopherol, 
folic acid, and fiber (Freudenheim et al., 1996).    
In a large population-based case-control study, Malin and colleagues (2003) 
investigated the intake of fruits, vegetables, and selected micronutrients in relat on to the 
risk of breast cancer and their results suggested that there is no overall association f 
breast cancer risk with total fruit or vegetable intake. However, there is significant 
inverse relationship between breast cancer risk and consumption of certain dark green 
vegetables, dark yellow-orange vegetables, and Chinese white turnips.  There was also n 
inverse relationship observed for all individual fruits except watermelon and apples.  
Dietary α-tocopherol was also related to a reduced risk of breast cancer (Malin et al., 
2003).  Fruit and vegetable consumption studies have shown conflicting results for 
effects on breast cancer risk.  This is an area that needs to be further investigated with 
closer investigation of individual components of fruits and vegetables.  
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 Another study evaluated the dietary intake of Hispanic and a subset of non-
Hispanic breast cancer survivors.  Hernandez-Valero et al. (2008) found that the overall 
diets of the two groups were similar and both have an intake of over 5 servings per day of 
fruits and vegetables.  Hispanics consumed significantly more lycopene than the non-
Hispanic white women which may be due to cultural differences and incorporation of 
more tomato products in the Hispanic diet (Hernandez-Valero et al., 2008).  The authors 
also suggested that diet plays a role in the survival of women diagnosed and treated for 
breast cancer, but needs to be further investigated to determine if higher lycopene intake 
among the Hispanic survivor participants provides greater protection against breast 
cancer recurrence or increased survival.  
Human observational studies demonstrated that oxidative stress increases with 
clinical progression of breast cancer and that some dietary antioxidants my have 
potential benefits in cancer therapy by their ability to induce programmed cell death 
(apoptosis) (Zimmermann, Bonzon, and Green, 2001).  For example, apple extracts have 
been shown to exert significant inhibitory effects on proteosomal activity of breast cancer 
cells by inhibition of TNF-α-induced NF-κB activation (Yoon and Liu, 2007).  Vitamins 
E and C given in combination inhibited apoptosis in endothelial cells by up-regulating the 
anti-apoptotic protein Bcl-2 and down-regulating the pro-apoptotic Bax (Haendeler, et 
al., 1996).  Studies have shown that vitamin E induced apoptosis in human breast cancer 
cells (Sigounas, et al., 1997).   
In addition to human studies, animal studies have also been conducted to 
determine the relationship of diet and cancer and to determine the mechanism of action. 
Moselhy and Al mslmani (2008) investigated the effects of lycopene alone or in 
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combination with melatonin to determine the inhibition of oxidative stress and 
carcinogenic effect of DMBA-induced mammary cancer in rats.  Protection agaist 
tumor-induced carcinogenesis was 66.5% and 80% in the rats receiving lycopene alone 
and combination of lycopene and melatonin, respectively.  Fewest deaths were observed 
in the lycopene with melatonin group followed by the lycopene group compared to the 
DMBA group.  There were higher antioxidant enzyme activities in the combination 
treated group followed by the lycopene treated group in comparison to control.  The 
investigators concluded that the combination of certain well known antioxidants may 
have anti-mammary tumor potential and need to be further investigated (Moselhy and Al 
mslmani, 2008).     
Another animal study investigated the effect of a dietary component, lariciresinol, 
a plant lignan, on mammary cancer in rats and MCF-7 human breast cancer xenografts in 
athymic mice (Saarinen et al., 2008).  The investigators found that nine-week 
administration of lariciresinol to rats reduced the growth of DMBA-induced mamary 
gland tumors measured as a cumulative tumor area. The inhibitory effect of lariciresinol 
was more pronounced in tumors that developed during the treatment period than those 
established already before the start of the treatment.  In the orthotopic MCF-7 xenograft 
group, intake of lariciresinol containing diet (100 mg/kg) by estradiol-maintained mice 
for 5 weeks significantly reduced MCF-7 tumor area.  Tumor weights were significantly 
lower in the group administered the lariciresinol diet compared to control mice.  The 
lariciresinol diet increased the number of apoptotic tumor cells according to the TUNEL 
assay.  Tumor vascularization and microvessel densities were also reduced by th  
lariciresinol diets compared to control. The investigators observed an inhibition in 
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mammary cancer growth in two different i  vivo models by lariciresinol suggesting its 
possible role in the prevention of one of the leading causes of death worldwide (Saarinen 
et al., 2008).   
The human and animal studies discussed above demonstrate the relationship 
between diet and cancer.  Although inconsistencies in findings exist, it has been shown 
that diet may play a role in the development and progression of breast cancer.  Fruits and 
vegetables have been investigated as well as particular components that are found in
these staples of the human diet.  It is recommended by several agencies to increase 
vegetable and fruit intake as dietary strategy to reduce risk of chronic disease and cancer 
(World Cancer Research Fund/American Institute for Cancer Research, 1997, Van Gils et 
al., 2005).  Further research is warranted so that we may better understand the importance 
of maintaining a healthy diet to prevent or inhibit further progression of this devastating 
and fatal disease. 
 
III. Grapes  
A. Components of grapes responsible for anti-cancer properties 
Plants in their natural environment undergo many stress factors.  These factors 
include drought, salinity, nutritional deficiency, insulation, adverse climate conditions, 
pollutants, pathogens, insects, and phytogaphy.  Their survival depends on natural 
compounds found in the plant that protect it from such stress factors; many of these 
natural compounds have recently become of particular interest to the nutrition and 
pharmacological industries due to their disease-counteractive effects (Iriti and Faoro, 
2006).   
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There are many compounds found in grapes that have become of recent interest to 
researchers in the field of nutrition.  Grape components have demonstrated antioxidant, 
cardioprotective, hepatoprotective, anticarcinogenic, antimicrobial, antiviral, central 
nervous system, dermatological, and antidiabetic effects (Nassiri-Asl and Hosseinzadeh, 
2009).  Active constituents of grapes that have been reported are polyphenolic 
compounds such as flavonoids, anthocyanins, and stilbene derivatives (Nassiri-Asl and 
Hosseinzadeh, 2009).  The amount of these constituents present in grapes depends on 
several factors including the cultivar, year of production (climate), site of production 
(geographic origin, soil quality, and fertilization), degree of maturation, and color (Shi et 
al., 2003).       
Polyphenols are found in the skin, pulp, and seeds of the grape; as much as 60 to 
70% are in the seeds, very low amounts in the pulp, and as much as 30% in the skin.  
Flavan derivatives are the common polyphenols and are found as dimers, trimers, and 
oligomers in the seed and are commonly referred to as procyanidins or proanthocyanidins 
(Zhao et al., 1999).  The amount of these constituents present in grapes depends on 
several factors including the cultivar, year of production (climate), site of production 
(geographic origin, soil quality, and fertilization), degree of maturation, and color (Shi et 







Flavonoids are antioxidants present in the grape skin and seeds (Yilmaz and 
Toledo, 2004); these compounds are flavan-3-ols which are colorless and include 
epicatechin and catechin.  The colored compounds are flavanones such as quercetin and 
red and blue anthocyanins (Shi et al, 2003). 
Anthocyanins are responsible for the blue, purple and red color of many plant 
tissues, including grapes (Prior and Wu, 2006).  Common anthocyanin compounds in 
grapes are glucosides, caffeoylglucosides, diglucosides of cyanidins, delphinidin, 
peonidin, petunidin, and malvidin (Wang et al., 2003). 
The major stilbene derivative found in grapes is resveratrol (Iriti and Faoro, 
2006).  This compound has become quite commonly used in the research field.  
There are many active compounds found in grapes which give grapes powerful anti-
carcinogenic capabilities. 
 
B. Grapes and breast cancer 
 Because of the numerous phenolic compounds found in grapes, these compounds 
have become of particular interest as of late on their role in the prevention of cancer.  The 
next section discusses studies that have been conducted on the relationship of grape 
intake and breast cancer. 
 
In vitro studies 
Singletary et al. (2007) examined the effects of anthocyanin-rich extract from 
Concord grapes and anthocyanin delphinidin on human breast epithelial cells with DNA 
damage from an environmental carcinogen, benzo[a]pyrene (BP).  Concord grape extract 
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(CGE) inhibited BP-induced DNA adduct formation in the MCF-10F cell line.  These 
findings indicate that in chemically induced breast carcinogenesis, CGE and select 
constituent anthocyanins may be considered as potential blocking agents (Singletary et 
al., 2007). 
Sharma and colleagues (2004) assessed the effects of grape seed extract (GSE) 
and Doxorubicin (Dox), a conventional chemotherapeutic agent, individually or in 
combination on MCF-7, MDA-MB468, and MDA-MB231 human breast carcinoma cell 
growth, cell-cycle progression, and apoptosis.  GSE and Dox dose- and time-dependently 
inhibited growth and induced death in these cancer cell lines.  Combination of GSE and 
Dox showed increased therapeutic effect in all the three cell lines.  The combination 
treatment also caused accumulation of MCF-7 cells in G1 phase possibly having an 
inhibitory effect on the G1-S transition in cell-cycle progression.  GSE caused apoptotic 
death in MCF-7 cells and comparable effect was observed in combination with Dox.  
MDA-MB468 cells treated with GSE showed strong apoptotic death and the combination 
of the two treatments caused significant increase in apoptotic death.  The authorss gge t 
that a combination of a dietary supplement like GSE along with a reduced dosage of a 
conventional chemotherapeutic agent such as Dox may enhance its therapeutic effects on 
breast cancer (Sharma et al., 2004). 
 Red wine also contains some polyphenols commonly found in red grapes and 
have been investigated for their role in breast cancer prevention.  Red wine polyphenols 
decrease in vitro breast cancer cell proliferation (Damianaki et al., 2000).  Hakimuddin 
and colleagues (2004) examined the anti-proliferative activity of three different structural 
classes of flavonoids from wine on breast cancer cell lines, MCF-10A and MCF-7, and 
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one normal human mammary epithelial cell line (HMEC).  HMECs were most sen itive 
to the inhibition of the flavonoids as compared to MCF-10A and MCF-7 cell lines.  The 
less hydrophobic fraction (the crude fraction) of the wine showed similar inhibitory 
effects on all three cell lines while the more hydrophobic fraction showed the most 
inhibition of MCF-7 cancer cell line proliferation but not the other two cell lines.  The 
authors suggest that these results may be attributed to flavonoid fractions and growth 
inhibition is highly dependent on flavonoid concentration.   They also suggested that it 
may be beneficial to increase these components in wine and thus increase the functional 
food value of the beverage (Hakimuddin et al., 2004).    
 Another study (Faria et al., 2006) evaluated the effects of procyanidin fractions on 
MCF-7 human breast carcinoma cells.  Catechin fractions (30 and 60 µg/mL) caused a 
decrease in cell viability and inhibition of cell proliferation of MCF-7 cells.  The 
procyanidin fractions that inhibited cell proliferation exhibited higher antioxidant 
activity.  The authors suggest that the antioxidant activity of procyanidins may be partly 
responsible for the effect on cell proliferation (Faria et al., 2006). 
 Mantena et al. (2006) examined the effects of grape seed proanthocyanidins 
(GSPs) in one mouse metastatic breast cancer cell line (4T1) and two human breast 
cancer cell lines (MCF-7, and MDA-MB-468).  4T1 cells treated with GSPs resulted in a 
dose-dependent inhibition of cell viability and proliferation as well as induction of 
apoptosis.  Similarly, treatment of the two human cell lines resulted in significant 
reduction in cell viability and concentration- and time-dependent manner.  Bcl-2 
expression was decreased and Bax expression increased in 4T1 cells with GSPs 
treatment, suggesting that this may be responsible for the induction of apoptosis in the 
 22
4T1 cells.  There was also a dose- and time-dependent increase in levels of cytochrome c 
Apaf-1 and cleaved caspase-3 with GSPs treatment (Mantena et al., 2006).  
 Overall, the findings of the in vitro studies demonstrate that components in grapes 
such as polyphenols and flavonoids inhibit cell proliferation and induce apoptosis.    
 
Animal studies 
Animal models have also been utilized to investigate the anti-cancer properties of 
grapes and its components. Mantena et al. (2006) gave immunocompetent Balb/c mice a 
control diet or diet consisting of 0.2% and 0.5% w/w GSPs.  Dietary GSPs significantly 
inhibited the growth of subcutaneous tumors and increased survival rate in immune 
competent Balb/c mice inoculated with 4T1 breast cancer cells.  GSP also inhibited 
metastasis of the 4T1 cells from the primary tumor site to the lungs, decreased expression 
of antiapoptotic Bcl-2, increased Bax, cytochrome c, and Apaf-1 expression as well  
activate caspase-3 in the tumors compared to control mice.  The authors suggest that the 
presence of cleaved caspase-3 in vivo further confirms that GSPs induce apoptosis in 
tumor cells through disruption of mitochondrial pathways (Mantena et al., 2006).      
Investigators have discovered that red wine polyphenols delay progression of 
mammary tumors in the transgenic in vivo model (Clifford et al., 1996).  Eng and 
colleagues (2003) investigated the relationship between estrogen, wine polyamide 
extract, and tumor development.  Female BALB/c-nu-nu, athymic, non-ovariectomized 
mice were implanted with 5 mg/60 day time-release androstenedione pellets and gavaged 
with water (CON) or various concentrations of wine polyamide extract for 42 days, and 
subcutaneously injected with MCF-7aro cells.  As the concentrations of wine extract 
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increased, estradiol and estrone levels decreased in comparison to control although it was 
not statistically significant (Eng et al., 2003).   
In another experiment (Eng et al., 2003), the effect of endogenous estrogens was 
eliminated by using athymic nude-ovariectomized female mice.  These mice showed a 
significant reduction in tumor size compared with the androstenedione control mice.  The 
3x concentrate-treated mice had the most dramatic suppression of tumor growth, having 
no MCF-7aro growth at injection site.  There was only a slight reduction in blood 
estrogen concentrations after treatment with increasing concentrations of wine extract.  
The authors suggest that based on the results of the study, in situ-produced estrogen has a 
more negative impact on ER-positive breast tumor growth than circulating estro en.  
Moreover, the effect of the grape seed extract may result from different phytochemicals 
other than procyanidin dimers in the extract (Eng et al., 2003).     
Chemopreventive efficacy of grape seed extract (GSE) against DMBA-induced 
mammary tumorigenesis was investigated using Sprague-Dawley rats (Kim et al., 2004).  
GSE at a 5% dose showed no effect on multiplicity of DMBA-induced mammary tumors; 
diet showed significant tumor attenuation.  Supplementation of 1.25% GSE showed no 
detectable chemopreventive effect (Kim et al., 2004).  This warrants further studies as to 
the exact mechanism of action of GSE on tumor induction and inhibition in order to 
know the potential benefits of the extract.      
In addition to grape seed extract, purple grape juice has also been used to examine
its effects on DMBA-induced rat mammary tumorigenesis and in vivo DMBA-DNA 
adduct formation (Jung et al., 2006).  Female Sprague-Dawley rats were provided with 
drinking water containing diluted Concord grape juice for three weeks prior to DMBA 
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intubation.  There was significant inhibition of in vivo mammary DMBA-DNA adduct 
formation and tumors.  During the first 11 weeks tumors were significantly suppressed in 
rats receiving the grape juice.  The constituents or combination of components in the 
Concord grape juice responsible for the adduct or tumor changes need to be further 
explored (Jung et al., 2006).  There need to be more studies conducted to eliminate the 
uncertainties related to the active antioxidant components in grapes.     
 
C. Resveratrol and breast cancer 
Resveratrol is a naturally occurring phytochemical that is found in approximately 
72 plant species, including grapes, peanuts, and various herbs.  It is present at particularly 
high concentrations in grape skin and is also abundant in red wine (Jang et al., 1997).  
Resveratrol is structurally similar to estrogens which may have implications for the 
compound as an anticancer agent in breast cancer (Figure 1).  It has been suggested that 
it plays an important role in cancer prevention as a therapeutic agent (Jang et al., 1997).  
Investigators observed that binding of resveratrol to estrogen receptor alpha activates 
transcription of genes regulated by estrogen (Gehm et al., 1997).  Studies have shown 
that resveratrol inhibits growth of both estrogen receptor alpha positive and negative cell 







Figure 1. Structure of resveratrol.                    
                                       
 
A few studies have focused on the possible molecular targets of resveratrol to 
explain its anti-proliferative/apoptotic effects.  The induction of cell cycle arr st by 
resveratrol has been associated to a decreased level of cyclin D1 (Joe et al., 2002), and 
up-regulation of both the oncosuppressor p53 and the cyclin kinase inhibitor 
p21/Wafl/CIP1 (Narayanan et al., 2003).  Resveratrol was shown to inhibit other known 
key regulators of cell proliferation such as PKC (Stewart et al., 1999).  Induction of cell 
death by resveratrol was shown to be associated to Bcl-2 phosphorylation (Tinhofer et al., 
2001), Bax mitochondrial translocation (Mahyar-Roemer et al., 2002), and inhibition of 
AKT and FAK activity (Brownson et al., 2002).  Resveratrol was also reported to inhibit 
ribonucleotide reductase, therefore interfering with DNA synthesis in proliferating cancer 
cells (Fontecave et al., 1998).  Moreover, resveratrol was shown to inhibit both the 
activity and transcription of COX2 (Subbaramaiah et al., 1998).   
Some studies show that low concentrations of resveratrol have been found to 
cause proliferation of ER-positive human breast cancer cells; whereas high 
concentrations have been found to inhibit the growth of both ER-positive and ER-
negative human breast cancer cell lines (Nakagawa et al., 2001).  Growth suppression by 
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resveratrol is the result of mid to late cell cycle arrest (Joe et al., 2002) and modulation of 
the apoptosis cascade (up-regulation of proapoptotic proteins Bax and Bak, down-
regulation of antiapoptotic protein Bcl-xL, and activation of caspase-3) (Nakagawa et al., 
2001).  
 
In vitro studies 
The effects of resveratrol on breast cancer using various breast cancer cell lines 
will be discussed in this section.  Exposure of MCF-7 human breast cancer cells to 
resveratrol (12.5-100 µM) for 48 hours resulted in a dose-dependent cell cycle arrest and 
apoptosis (Kim et al., 2004).  The anti-proliferative effect of the compound was 
associated with an up-regulation of tumor suppressor p53 and cyclin-dependent kinase 
(Cdk) inhibitor p21.  The increase in apoptosis by resveratrol was connected with an 
increase in pro-apoptotic protein, Bax, expression, decrease in anti-apoptotic protein, Bcl-
2 and Bcl-xL, expression, and activation of caspase-9.  Cyclins and cyclin kinases 
expressed in the early cell cycle processes showed marked inhibition indicating cell cycle 
arrest in the G1 and S-phases.  Cells treated with high concentrations of resveratrol (50 
µM) showed an accumulation of cells in the early phases of the cell cycle as compared to 
the controls which showed an increased amount of cells in the late and final phases of the 
cell cycle after 48 hours (Kim et al., 2004).  
Laux and colleagues (2004) examined the possible role of p53-dependent 
pathways in prevention of breast cancer by resveratrol.  Five human breast cancer cell 
lines and a normal cell line, MDA-MB231, MDA-MB 453, MDA-MB 468, BT 20, 
SKB3, and N132 1N1, respectively were treated with different concentrations of 
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resveratrol to determine the correlation between p53 and resveratrol-induced apoptosis.  
Apoptosis was induced in only one cell line, MDA-MB-468, specifically at 10 mM and 
40 mM concentrations of resveratrol.  The lower concentration of resveratrol showed 
indications of apoptosis but to a lesser extent.  The cell lines that failed to show any 
changes characteristic of apoptosis have abundant protein levels of p53 (tumor 
suppressor) or mutant p53 genes and the cell line that showed evidence of apoptosis had 
low levels of this protein. The investigators suggest that these findings confirm that 
resveratrol may be used as effective indicator of p53 status of breast cancer cells.  Further 
investigation of the mechanism by which resveratrol induces apoptosis in cells with wild-
type p53 is needed.  This will further clarify any potential that resveratrol may have in the 
treatment and prevention of cancer (Laux et al., 2004).     
The effect of the (E)- and (Z)-isomers of resveratrol on MCF-7 breast cancer 
cellular proliferation and the luciferase activity of the MVLN cell line was investigated 
by Basly and colleagues (2000).  Their findings showed that the (Z)-isomer of resveratrol 
was less effective than the (E)-isomer on the inhibition of cellular proliferation in both 
MCF-7 and MVLN cell lines.  Further research is needed on the effect of the different 
isomers of resveratrol to determine anticancer properties of each (Baslyet l., 2000).   
In MCF-7 breast cancer cells, apoptosis was concentration-dependent and found 
to be highest at a concentration of 150 µM (Pozo-Guisado et al., 2005).  It was also 
observed that in a dose-dependent manner resveratrol decreased Bcl-2 protein content, an 
anti-apoptotic protein.  This decrease was inversely proportional to the dose of 
resveratrol.  Only very low levels of the protein were observed at 150 µM, the highest 
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concentration of resveratrol treatment.  Resveratrol was unable to induce caspase-3 and 
caspase-8 activity, pro-apoptotic enzymes, in the cell line (Pozo-Guisado et al., 2005).  
An analogue of resveratrol (3,3’,4,4’,5,5’-hexahydroxystilbene) was shown to 
inhibit cell growth in three breast cancer cell lines in a concentration-depen nt manner 
(Murias et al, 2008).  In two of the cell lines (ZR-75-1 and T47D) caspase-3 and caspase-
9 were detected while all three caspases (caspases -3, -8, and -9) showed activation in 
MDA-MB-231 cells.  The three cell lines exhibited a concentration-dependent loss of 
mitochondrial potential while 50 µM of the analogue caused a time-dependent loss.  
After 24 hours of incubation with 50 µM of the analogue, cells lines exhibited apoptotic 
changes and signs of necrosis.  There was a time-dependent increase of p53, a tumor 
suppressor that acts in processes that affect cellular proliferation and survival, in all three 
cell lines.  The highest concentration of p53 was observed after 24 hours of incubation 
with the resveratrol analogue.  The results of this study suggest that apoptosis induced by 
the resveratrol analogue was mitochondrial in origin as shown by the dissipation of 
mitochondrial membrane potential that is closely followed by caspase-9 activation 
(Murias et al, 2008).  
Zahid and colleagues (2008) reported that resveratrol dose- and time-dependently 
induced expression of the phase II enzyme quinine oxidoreductase (NQO1), a protective 
enzyme, by two- to three-fold in human breast epithelial cells, MCF-10.  When cells were 
preincubated with resveratrol and estrogen-containing medium, NQO1 induction caused a 
2-fold decrease in DNA adduct formation at all three doses of estrogen.  From these 
results, the investigators suggest that resveratrol induces the protective enzyme NQO1 by 
reducing catechol estrogen quionones which react with DNA to form depurinating 
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adducts that can cause damage to tissues that can possibly lead to carcinogenesis (Zahid 
et al., 2008).   
 
Animal studies       
Resveratrol has been shown to exert anti-carcinogenic activity in animal models 
of mammary carcinogenesis.  Bhat et al. (2001) reported that dietary administration of 10 
or 100 mg/kg resveratrol 5 days per week, starting 7 days before administration of a 
cancer-inducing compound and continuing for the entire period of the study, suppressed 
induction of mammary carcinomas.  At the end of the study (120 days after the 
administration of the cancer –inducing compound), 100mg/kg resveratrol was found to 
have reduced the incidence of tumors, decreased the total number of tumors, and 
increased the latency, compared with untreated controls.  Resveratrol at a dose of 10 
mg/kg had significantly weaker effects (Bhat et al., 2001).  
 Resveratrol was found to significantly inhibit tumor growth in female athymic 
mice injected subcutaneously with MB-MDA-231 human breast cancer cells (Garvin et 
al., 2006).  After three weeks, tumors in the untreated group were five times largr than 
those of the resveratrol-treated group after only three weeks.  Moreover, an increase in 
apoptosis and decreased angiogenesis was observed in resveratrol-treated tumors 
compared to control (Garvin et al., 2006).   
 A study by Whitsett et al. (2006) showed that rats given dietary resveratrol 
coupled with DMBA to induce carcinogenesis had significantly lower tumor multiplici y 
and significantly longer tumor latency compared to control.  Chemically-induced 
mammary tumor incidence per rat was lowest in the group receiving resveratrol.  
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Compared to control animals, resveratrol-exposed rats had significantly delaye  onset of 
first mammary tumor. There was an increase in mammary epithelial cel poptosis in the 
terminal end buds and significantly reduced cellular proliferation.  The authors suggest 
that this coupling could create an environment less susceptible to chemical 
carcinogenesis in the mammary gland (Whitsett et al., 2006).    
 
D. Oklahoma grapes 
 The Oklahoma grape industry has had a difficult time in the past sustaining the 
growth and distribution of grapes for product creation and use.  Not only does the 
Oklahoma climate produce some difficulty, but Prohibition laws in the early 1920s 
dampened the industry (McCraw et al., 2005).  Demand for grapes in Oklahoma 
increased in the 1970s and declined in the 1980s.  Of the varieties that have survived the 
years of difficulty, most contain native Vitis parentage which has enabled them to 
withstand the harsh Oklahoma weather.  The efforts of researchers have enabled the 
release of years of work on desirable fruit characterstics, vine vigor, disease resistance, 
productivity, drought resistance, cold hardiness, and fruit acceptability for juice, elly, 
table use, and wine production.   
 Since the Oklahoma grape industry has suffered hardships, commercial grape 
production is relatively new to many areas of Oklahoma.  There are many things to 
consider when planning a vineyard, including microclimate, soil, irrigation, and disease 
and pest management for example (McCraw et al., 2005).  There has been a steady 
increase in grape production since the mid-1990s.  There has also been a recent increase 
in Oklahoma vineyards and grape production; 375 acres of grapes were grown in 2002 
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and increased to 525 acres in 2005.  Oklahoma wineries are also on the rise; there were 
four licensed wineries in 2001 and as of 2007, there are 50.  These numbers show the 
expansion of the Oklahoma grape and wine industry in a short period of time and the 
importance of the research industry in producing the disease resistant, cold hardy 
varieties.  Of the total acreage in Oklahoma used for grape production, 60 percent is for 
the production of red grapes.  Lincoln County reports the largest acreage and more than 
10 vineyards.  There are more than 40 grape varieties currently being produced in 
Oklahoma (Stafne, 2005). 
 The Oklahoma grape industry has greatly expanded in the past 50 years.  Many 
researchers have added to the growth of the industry through efforts to create and produce 
types of grapes able to resist disease and Oklahoma weather changes.  Since the stat ’s 
industry is still relatively new and expanding, the research being conducted using 
Oklahoma grape varieties to assess their potential in disease prevention and treatment is 
new.  This is one of the reasons why we chose an Oklahoma grape variety, Rubaiyat, to 
assess its role in preventing breast cancer with widely used MCF-7 human breast cancer 
cell line.                        
 
E. Rubaiyat grapes 
It has been demonstrated that phenolic compound found in grapes play a role in 
the prevention of breast cancer.  As mentioned earlier, phenolic content of grapes can be 
influenced by several factors such as the growing environment and the variety of grapes.  
To our knowledge, this is the first study investigating the cancer preventing properties of 
Rubaiyat grapes.  We have chosen this particular grape variety due to its relatively high 
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total phenolic content.  Our study examines the effect of the phenolic-rich extract of 
Rubaiyat grapes, a native Oklahoma grape, in inhibiting cellular proliferation nd 
inducing apoptosis using a commonly used breast cancer cell line, human MCF-7.    
The Rubaiyat grape is a cross between Seibel 5437 and ‘Bailey’ made at 
Oklahoma State University developed in 1952 by Herman Hinrichs.  Seibel is a black 
grape that ripened early to midseason, cold hardy, and has medium size clusters and 
berries (Stafne, 2006).  The Rubaiyat seed was first germinated in 1953 after which it was 
grown in a nursery for two years.  It was placed into the field at the Pecan and Fruit 
Experiment Station (Perkins, OK) in 1955, and fruit was first observed in 1957 (Stafne, 
2006).  Rubaiyat is a dark blue-black grape variety with medium-sized clusters and 
berries that ripen in mid-August.  The variety has good to very good disease resistance.  It 
produces a very dark red juice which contains 19% sugars and tartaric acid levels of 







Preparation of Rubaiyat grape extract 
Oklahoma grapes of the Rubaiyat variety were obtained from Perkins Research 
Station (Perkins, OK).  100 g fresh grapes were cleaned and dried before extraction of 
phenolics using a method previously reported (Sun and Liu, 2006).  Grapes were pureed 
with a solution of methanol, ethanol, and water (50:25:25, v:v:v).  The puree was 
sonicated in ice for 30 minutes and centrifuged for 30 minutes at 10,000 g at 4˚C. The 
puree was then filtered under vacuum through a #2 Whatman filter paper on a Buchner 
funnel.  The filtered extract was roto-evaporated until no more than approximately 10 mL 
was remaining.  The concentrated extract was run through a C18 column (Waters, 
Taunton, Massachusetts) that was pre-conditioned with methanol and Millipore wate to 
obtain polyphenols and discard proteins and sugars.  Polyphenols were eluted from the 
column with methanol.  The extract was roto-evaporated once more to evaporate the 
methanol. The remaining extract was dissolved in water and aliquoted into cryovial tubes 
in 1.0 mL quantity and stored at -80˚C until needed. 
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Determination of total phenolic content of the grape extract 
The total phenolic content of the grape extract was analyzed by the Folin-
Ciocalteu colorimetric method described previously (Sun and Liu, 2006).  Briefly, gallic 
acid (Sigma-Aldrich Chemical Co., St. Louis, MO) dissolved in 40% ethanol was used as 
the standard (0-1000 µM).  Appropriate dilutions of grape extract and standards were 
oxidized with Folin-Ciocalteu reagent (Sigma-Aldrich Chemical Co., St. Louis, MO) and 
the reaction was neutralized with 20% sodium carbonate (Fisher Scientifi, Fair Lawn, 
NJ), followed by the addition of Millipore water.  After 90 minutes, the absorbance was 
measured against acidified distilled water as the blank at 760 nm using a BioTek Synergy 
HT microplate reader (BioTek Instruments Inc., Winooski, VT).  Analyses were done in 
triplicate and the results were expressed as mean µg/mL.   
 
Determination of total flavonoid content of the grape extract 
Total flavonoid content of the grape extract was determined using a colorimetric 
method described previously (Sun and Liu, 2006).  Briefly, 1 mL of grape extract and 
equivalent solution of catechin (Sigma-Aldrich Chemical Co., St. Louis, MO) in water as 
standard (0-200 mg/L) was mixed with distilled water followed by addition of 5% 
sodium nitrite solution (Sigma-Aldrich Chemical Co., St. Louis, MO).  After 5 minutes, 
10% aluminum chloride solution (Fisher Scientific, Fair Lawn, NJ) was added and 
allowed to stand for 6 minutes followed by addition of 1 M sodium hydroxide (Sigma-
Aldrich Chemical Co., St. Louis, MO).  Total volume of the mixture was adjusted with 
distilled water and the absorbance was immediately measured at 510 nm using the 
BioTek Synergy HT microplate reader (BioTek Instruments Inc., Winooski, VT).  An 
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equivalent dilution of acidified distilled water was used as blank.  Analyses were done in 
triplicate and the results were expressed as mean µg/mL.   
 
Determination of anthocyanin content of the grape extract 
Anthocyanin content of the grape extract was determined using a method 
previously described (Sun and Liu, 2006).  Grape extract was diluted with two different 
buffers separately, one with potassium chloride buffer (0.025 M, pH 1.0) (Sigma-Aldrich 
Chemical Co., St. Louis, MO) and the other with sodium acetate buffer (0.4 M, pH 4.5) 
(Sigma-Aldrich Chemical Co., St. Louis, MO).  Grape extract was diluted with buffers in 
a 1:9 ratio of extract to buffer in a 96-well plate and equilibrated for 15 minutes in he
dark.  The absorbance of each dilution was read at 510 nm and 700 nm using a Biotek 
Synergy HT microplate reader (Biotek Instruments Inc., Winooski, VT) and measured 
against a blank cell filled with equivalent dilution of acidified distilled water.  Total 
monomeric anthocyanins content was calculated according to the equation.   
  Anthocyanin concentration =∆A x MW x 1000/(ε x C) 
A, absorbance [(A510 – A700) pH 1.0 – (A510 – A700) pH 4.5 = ∆A]; C, grapes 
concentration (9/1); MW = 449.2; and ε = 26, 900 
Analyses were done in triplicate and the results were expressed as a mean µg/mL. 
 
Cell culture and resveratrol 
The human breast cancer cell line MCF-7, an ER+ epithelial cell line, was 
obtained from American Type Culture Collection (ATCC, Rockville, MD) and cultured 
in a T-75 flask containing 25 mL Eagles minimum essential medium (ATCC, Rockville, 
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MD) supplemented with 10% fetal bovine serum (FBS) (Sigma-Aldrich Chemical Co., 
St. Louis, MO), 1% penicillin-streptomycin (Sigma-Aldrich Chemical Co., St. Louis, 
MO), and 10 mg/mL bovine insulin (Sigma-Aldrich Chemical Co., St. Louis, MO) and 
maintained in a 37˚C incubator with 5% CO2.  Resveratrol was purchased from Sigma-
Aldrich Chemical Co., (St. Louis, MO, USA) and dissolved in DMSO (Fisher Scientific, 
Fair Lawn, NJ) as a stock solution at 200 mM concentration, and stored in aliquots at 
room temperature.   
 
Measurement of inhibition activity towards MCF-7 cell proliferation by 
sulforhodamine B assay   
The cytotoxic effects of grape extract and resveratrol were measured by the 
sulforhodamine B (SRB) assay (Houghton et al., 2007).  Cells were maintained at 37˚C 
with 5% CO2 in minimum essential medium alpha medium (MEM) containing 10 mg/mL 
bovine insulin, 50 units/mL penicillin, 50 units/mL streptomycin, and 10% fetal bovine 
serum.  MCF-7 cells in growth media were placed in each well of a 96-well flat-bottom 
plate at a concentration of 5 x 103 cells/well.  After 24 hours of incubation at 37˚C with 
5% CO2, the growth medium was replaced by media containing different concentrations 
of Rubaiyat grape extract (11.25, 22.5, 45, and 228 µg/L) or resveratrol (50, 100, 200, 
and 1000 µM which is equivalent to 11.25, 22.5, 45, and 228 µg/L of Rubaiyat grape 
extract, respectively).  Control group received growth medium or growth medium with 
0.1% DMSO.  After 48 or 72 hours of incubation with Rubaiyat grape extract or 
resveratrol, cells were fixed by the addition of 200 µL of 40% ice-cold trichloroacetic 
acid (Sigma-Aldrich, St Louis, MO) for one hour at 4ºC.  Cells were then washed five 
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times with distilled water and air-dried.  Sulphorodamine B solution (Sigma-Aldrich, St. 
Louis, MO) in 1% acetic acid (0.4% w/v) was added to each well and allowed to stain for 
30 minutes at room temperature.  SRB solution was removed and the plate was washed 
five times with 1% (v/v) acetic acid to remove unbound dye and air-dried.  The bound 
SRB was solubilized by adding 100 µL of 10 mM unbuffered tris base (pH 10.5) to each 
well and shaken for 5 minutes on a shaker platform.  Cytotoxicity of grape extract and 
resveratrol was determined at 48 and 72 hours from the SRB optical density at 492 nm 
reading from a Biotek Synergy microplate reader (Biotek Instruments Inc., Winooski, 
VT) Cell proliferation was expressed as % of control samples.  Experiment was repeated 
three times in triplicate to determine the cytotoxic activity. 
 
Nuclear staining with 4’6-diamidino-2-phenylindole (DAPI) 
The apoptotic effects of the Rubaiyat grape extract and resveratrol were measured 
by the DAPI assay (Lewis-Wambi et al., 2009).  Cells were maintained at 37˚C with 5% 
CO2 in minimum essential medium alpha medium (MEM) containing 10 mg/mL bovine 
insulin, 50 units/mL penicillin, 50 units/mL streptomycin, and 10% fetal bovine serum.  
MCF-7 cells in growth media were seeded in a 6-well plate at a concentratio  of 2.5 x 105 
cells/well.  After 24 hours of incubation at 37˚C with 5% CO2, the growth medium was 
replaced by media containing different concentrations of grape extract (11.25, 22.5, 45, 
and 228 µg/L) or resveratrol (50, 100, 200, and 1000 µM which is equivalent to 11.25, 
22.5, 45, and 228 µg/L, respectively).  Control group received of growth medium or 
growth medium with 0.1% DMSO.  After 48 or 72 hours of incubation, old media was 
taken off and discarded and cells were washed three times with PBS, and then 
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resuspended for 20 minutes in 4% PBS-buffered paraformaldehyde solution containing 
10 µg/mL DAPI (Sigma-Aldrich, St. Louis, MO).  Cells were then washed with PBS two 
times and observed using a fluorescence microscope (Nikon Eclipse TE2000-U, Japan) at 
excitation wavelength of 350 nm.  Apoptosis was visualized with the naked eye.  DAPI is 
a blue fluorescent nucleic acid stain that preferentially stains double-stranded DNA by 
attaching to AT clusters in the DNA minor groove.  One molecule of dye binds for each 3 
base-pairs (Kapuscinski and Szer, 1979).  
 
Expression of apoptotic genes, Bax and Bcl-2, by real-time RT-PCR 
  Apoptosis induction was assessed in MCF-7 cells using real time RT-PCR to 
examine Bax and Bcl-2 gene expression.  Cells were maintained at 37˚C with 5% CO2 in 
minimum essential medium alpha medium (MEM) containing 10 mg/mL bovine insulin, 
50 units/mL penicillin, 50 units/mL streptomycin, and 10% fetal bovine serum.  MCF-7 
cells in growth media were seeded in a 6-well plate at a concentration of 2.0 x 106 
cells/well.   After 24 h of incubation at 37˚C with 5% CO2, the growth medium was 
replaced by media containing different concentrations of grape extract (11.25, 22.5, and 
45 µg/mL) or resveratrol (50, 100, and 200 µM which is equivalent to 11.25, 22.5, and 45 
µg/mL, respectively). Control group received growth medium or growth medium wth 
0.1% DMSO.   
After 48 hours of incubation, media was taken off and RNA extracted with 800 
µL STAT-60 solution (Tel-Test Inc., TX).  Samples were gently mixed and transfe red 
into RNase-free microfuge tubes and incubated at room temperature in order to promote 
complete dissociation of RNA-protein complexes.  Chloroform (Sigma-Aldrich, St. 
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Louis, MO) was added to each sample, shaken vigorously, incubated at room 
temperature, and centrifuged at 12,000 x g at 4 ºC for 15 minutes. The aqueous phase 
containing RNA was transferred to a new RNase-free centrifuge tube.  Isopropanol 
(Sigma-Aldrich, St. Louis, MO) was added to each sample, vortexed, centrifuged at 
12,000 x g at 4ºC for 10 minutes, and the RNA pellet was saved.  RNA pellet was rinsed 
with 70% ethanol and air-dried for 3-5 minutes.  RNA was reconstituted with 30 µL 
DEPC-H2O, and the concentration of the RNA was determined on a NanoDrop ND-1000 
spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA).  Samples were stored 
at -80ºC until further analyses.   
For complementary DNA synthesis, DNase mix (Roche, Indianapolis, IN), 10x 
PCR buffer (Roche, Indianapolis, IN), DEPC-H2O and 25 mM MgCl2 (Sigma-Aldrich, 
St. Louis, MO) were mixed to get a DNase master mix.  The master mix was added to 
each RNA sample and placed in a thermocycler to incubate at 37ºC for 30 min.  The 
enzyme present in the samples was then heat inactivated at 75ºC for 10 min.  A reverse 
transcription was performed by mixing 5x buffer (Invitrogen, Carlsbad, CA), 0.1 M DTT 
(Invitrogen, Carlsbad, CA), dNTP mix (Promega, Madison, WI), 0.8 mg/mL pdN6 
(Roche), DEPC-H2O, and RTase (Invitrogen) to each sample. Samples were incubated in 
a thermocycler at 25ºC for 10 min, 42ºC for 50 min, and 72ºC for 10 min, then a 4ºC soak 
cycle.   
Each real-time reaction was performed using SYBR Green chemistry (Applied 
Biosystems, Foster City, CA). Primer Express Software (Perkin-Elmer Life Sciences) 
was used to design primers for each gene (Valasek et al., 2007).  Primers were validat d 
by analysis of template titration and dissociation curves (Valasek et al., 2007).    
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 Genes involved in cellular apoptosis induction, Bax and Bcl-2 (pro- and anti-
apoptotic proteins) were assessed.  Cyclophilin was the housekeeping gene.  Primer 
sequences as follows: hBAX-QF1-5'TGGAGCTGCAGAGGATGATTG,  hBAX-QR1- 
5'GCTGCCACTCGGAAAAAGAC, hBCL2-QF1- 5'GGGATGCCTTTGTGGAACTG, 
hBCL2-QR1- 5'CAGCCAGGAGAAATCAAACAGA,                                           
hCyclo-QF- 5'TGCCATCGCCAAGGAGTAG, hCyclo-QR-
5'TGCACAGACGGTCACTCAAA.  Amplification of RNA was detected constantly by 
real-time quantitative PCR using an ABI Fast 7900HT Real-Time PCR System (Applied 
Biosystems, Foster City, CA).  Cycles included one 2 minute hold (50˚C); one 10 minute 
denaturation (95˚C); 40 cycles of denaturation (95˚C for 15 seconds).   All real-time PCR 
results were analyzed using the comparative cycle number at threshold (CT) method.   
 
Statistical analyses 
 Statistical analyses involved computation of least square means and standard 
deviation (SD) for each of the treatment groups.  Analyses of variance (ANOV) was 
conducted using SAS version 9.1 (SAS Institute, Cary, NC) with PROG GLM to 
determine significance of treatment, concentration, and duration of treatment effects.  If 
post hoc analysis shows statistical significance, Fisher’s least square me ns separation 
test was used to determine and compare the significant differences among the means.  







Total phenolic, flavonoid, and anthocyanin content of the grape extract 
Total phenolic content of the Rubaiyat grape extract used in the study as 
determined by the Folin-Ciocalteau method was found to be approximately 1140 µg/mL 
(Table 1).  Anthocyanin and flavonoid of the grape extract was determined to be 
approximately 66 and 620 µg/mL, respectively (Table 1).   
  
Cell proliferation by sulforhodamine B assay  
The sulforhodamine B assay was used to measure the cytotoxicity on human 
MCF-7 breast cancer cells of various concentrations of treatment with Rubaiyat grape 
extract or resveratrol after 48 and 72 hours.  Overall, there was no significant difference 
in treatment duration (48 vs 72 hours) (Table 2).  However, looking at the individual 
treatment, cellular proliferation was significantly reduced by resveratrol after 72 hours 
compared to treatment duration of 48 hours (Figure 2).  This reduction in cellular 
proliferation was not observed with the Rubaiyat grape extract (P= 0.1402) (Figure 2).  
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Looking at the effect of concentration (regardless of treatment), there was a 
significant difference in cellular proliferation with different concentrations (Table 2).  
Cellular proliferation was significantly reduced starting at 22.5 µg/mL and lowest at 228 
µg/mL (Table 2).  There was statistical significance when comparing concentration with 
treatment with time (P = 0.0078) (Table 2).  Looking at resveratrol alone, cellular 
proliferation was significantly reduced starting at 11.25 µg/mL(50 µM) and the two 
highest concentrations (45 and 228 µg/mL, equivalent to 200 and 1000 µM, respectively) 
had the highest inhibition of cellular proliferation after treatment for 48 hours; although 
the two highest concentrations were not statistically different from each other (Figure 3).  
A similar pattern was observed for 72 hours of treatment with resveratrol (Figure 3).   
It takes more Rubaiyat grape extract to inhibit cellular proliferation of MCF-7 
breast cancer cells in comparison to resveratrol (Figure 4).  Rubaiyat grape extract at 228 
µg/mL is the only concentration that inhibited MCF-7 cellular proliferation at 48 and 72 
hours of treatment (Figure 4).  It is interesting to note that Rubaiyat grape extract at 
11.25 µg/mL has the highest MCF-7 cell proliferation (Figure 4).     
 
Nuclear staining with DAPI 
The apoptotic effects of resveratrol and grape extract after 48 and 72 hours of 
treatment were measured by the 4’6-diamidino-2-phenylindole (DAPI) assay (Figures 5 
and 6).  Treatment for 48 hours with Rubaiyat grape extract at 228 µg/mL showed the 
most marked induction of apoptosis on human MCF-7 breast cancer cells compared to 
the control (Figure 5).  Cells were far less numerous and misshapen, possibly indicating 
membrane blebbing, and smaller in size, all common apoptosis characteristics.  These 
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characteristics were observed in a dose-dependent manner (Figure 5).  Resveratrol-
treated cells showed these same characteristics in a dose-dependent mannr and were 
observed starting at the lowest concentration (11.25 µg/mL= 50 µM) and were most 
marked at 228 µg/mL concentration (1000 µM) (Figure 5).  Grape extract and resveratrol 
treatment for 48 hours showed similar results at their highest treatment concentrations 
(228 µg/mL= 1000 µM) (Figure 5).     
At 72 hours of treatment with Rubaiyat grape extract, 228 µg/mL concentration 
showed greatest apoptosis induction (Figure 6).  Grape extract treatment showed dose-
dependent apoptotic induction (Figure 6).  Cells showed characteristics of apoptosis, 
such as membrane blebbing, reduction in cell size, and were less numerous.  Resveratrol 
treatment showed characteristics of apoptosis induction at the lowest concentration 
(11.25 µg/mL= 50 µM) and greatest apoptosis induction at 228 µg/mL (1000 µM) after 
72 hours (Figure 6).  It exhibited dose-dependent apoptosis induction and similar 
apoptosis characteristics.  Grape extract treatment at 228 µg/mL concentration exhibited 
less prominent apoptotic characteristics than resveratrol at 228 µg/mL (1000 µM) 
(Figure 6).  Apoptosis induction by both resveratrol and grape extract was both dose- and 
time-dependent with the highest concentration of each treatment showing most prominent 
apoptotic characteristics (Figure 6).   However, all these data analyses need to be 
interpreted with caution as apoptosis visualization was done using the naked eye and not 





Expression of apoptotic genes, Bax and Bcl-2, by real-time RT-PCR 
The expression of pro- and anti-apoptotic markers was determined by quantitative 
real-time polymerase chain reaction.  There was no significant differenc  between 
resveratrol and Rubaiyat grape extract in the relative mRNA expression of the Bax gene 
(Table 3).  Moreover, there was no significant difference in the relative mRNA 
expression of Bax with different concentrations of both resveratrol (Figure 7 and Table 
3) and Rubaiyat grape extract (Figure 8 and Table 3). 
 The relative mRNA expression for Bcl-2 tended (P= 0.0580) to be lower with 
Rubaiyat grape extract compared to resveratrol (Table 3).  Moreover, there was a 
significant difference in the relative mRNA expression of this gene with different 
concentrations of Rubaiyat grape extract and resveratrol (Tab e 3).  Treatment with  
45 µg/mL (200 µM) of resveratrol significantly down-regulated gene expression of Bcl-2 
(Figure 7).  Lower concentrations of resveratrol (11.25 and 22.5 µg/mL which is 
equivalent to 50 and 1000 µM, respectively) did not reduce Bcl-2 gene expression 
(Figure 7).  However, Rubaiyat grape extract was able to significantly reduce gene 









Table 1. Total phenolic, anthocyanin, and flavonoid content of the Rubaiyat grape extract 





1Total phenolic, anothocyanin, and flavonoid content were determined by Folin- 
Ciocalteu, gallic acid colorimetric, and catechin colorimetric methods, respectively. 


































Parameter1 Amount (µg/mL)2 
Total phenolic  1140.5 ± 45.0 
Anthocyanin 65.6 ± 17.7 
Flavonoid  619.5 ± 40.6 
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Table 2. Effect of resveratrol and Rubaiyat grape extract treatment for 48 and 72 hours 
on MCF-7 human breast cancer cell proliferation 1 
 




Concentration effect (µg/mL )   






Treatment effect  
Resveratrol 53.4±27.1B 
Rubaiyat grape extract 91.3±27.4A 
 







1Cell proliferation was assessed by the sulforhodamine B assay. Values are mean ± SD, 
experiment was repeated 3 times. Values that do not share the same letters were 



















Figure 2. Effect of treatment duration with resveratrol and Rubaiyat grape extract on 

































1 Cell proliferation was assessed by the sulforhodamine B assay.  Values are mean ± SD, 
experiment was repeated 3 times.  Bars that do not share the same letters are significantly 























P = 0.0001 
P = 0.1402 
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Figure 3. Effect of treatment with different concentrations of resveratrol for 48 or 72 































1 Cell proliferation was assessed by the sulforhodamine B assay.  Values are mean ± SD, 
experiment was repeated 3 times.  Bars that do not share the same letters are significantly 
(P < 0.05) different from each other.  Small letters are comparison of different 
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Figure 4. Effect of treatment with different concentrations of Rubaiyat grape extract for 


































1 Cell proliferation was assessed by the sulforhodamine B assay.  Values are mean ± SD, 
experiment was repeated 3 times.  Bars that do not share the same letters are significantly 
(P < 0.05) different from each other.  Small letters are comparison of different 
































Figure 5. Representative picture of the effect of treatment with different concentratio s 
of resveratrol and Rubaiyat grape extract for 48 hours on MCF-7 human breast cancer 
cellular apoptosis as assessed by the 4’6-diamidino-2-phenylindole (DAPI) assay
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                                                                        Rubaiyat grape extract  
Resveratrol (22.5 ug/mL= 100 uM)  (total phenolic= 22.5 ug/mL) 
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                                       Rubaiyat grape extract 
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Figure 6. Representative picture of the effect of treatment with different concentratio s 
of resveratrol and Rubaiyat grape extract for 72 hours on MCF-7 human breast cancer 
cellular apoptosis as assessed by the 4’6-diamidino-2-phenylindole (DAPI) assay
 













Resveratrol (11.25 ug/mL= 50 µM)                Rubaiyat grape extract  













Resveratrol (22.5 ug/mL= 100 µM)               Rubaiyat grape extract  






       







Resveratrol (45 ug/mL= 200 µM)                   Rubaiyat grape extract  













Resveratrol (228 ug/mL= 1000 µM)           Rubaiyat grape extract 






























Table 3. Effect of resveratrol and Rubaiyat grape extract treatment for 48 hours on 
apoptotic gene expression (Bax and Bcl-2) 1 
 
Treatment effect Bax relative mRNA (pro-
apoptotic) 
Bcl-2 relative mRNA 
(anti-apoptotic) 
Resveratrol  0.91±0.22 0.70±0.37 
Rubaiyat grape extract 1.01±0.18 0.51±0.38 
 
Concentration effect (µg/mL) 
0 1.00±0.12 1.00±0.12a 
11.25 0.92±0.24 0.72±0.39b 
22.5 1.02±0.19 0.48±0.23b 
45 0.90±0.26 0.20±0.04c 
 
P values 0.1806 0.0007 
Concentration 0.5423 0.0002 
Treatment 0.2348 0.0580 
Treatment*concentration 0.1012 0.1747 
 
1 Apoptotic gene expression was assessed by the real-time RT-PCR. Values are mean ± 


























Figure 7. The effect of resveratrol treatment for 48 hours on relative mRNA expression 


























1 Apoptotic gene expression was assessed by the real-time RT-PCR. Values are mean ± 
SD.  Bars that do not share the same letters are significantly (P < 0.05) different from 




























Figure 8. The effect of Rubaiyat grape extract treatment for 48 hours on relative mRNA 



























1 Apoptotic gene expression was assessed by the real-time RT-PCR. Values are mean ± 
SD.  Bars that do not share the same letters are significantly (P < 0.05) different from 











The aim of this study is to compare the effect of Rubaiyat grape polyphenolic-rich 
extract to that of resveratrol in (a) inhibiting cell proliferation and (b) inducing apoptosis 
in the human breast cancer MCF-7 cell line. We chose the Rubaiyat grape because it is 
relatively high in polyphenol content and is a grape variety native to Oklahoma. The total 
phenolic content of the Rubayat grape extract used in our study, determined by the Folin-
Ciocalteau method, was approximately 1140 µg/mL. For our study, we used the whole 
grapes for extracting the phenolic compounds. However, polyphenols are found in the 
skin, pulp, and seeds of the grape; as much as 60 to 70% are in the seeds, very low 
amounts in the pulp, and as much as 30% in the skin (Zhao et al., 1999).  We did not 
attempt to extract the phenolic compounds from each of the components of grapes.       
Active constituents of grapes that may possess anti-carcinogenic properties are 
polyphenolic compounds such as flavonoids, anthocyanins, and stilbene derivatives 
(Nassiri-Asl and Hosseinzadeh, 2009). Flavan derivatives are common polyphenols in 
grapes and found as dimers, trimers, and oligomers in the seed and are commonly 
referred to as procyanidins or proanthocyanidins (Zhao et al., 1999).
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Flavonoids are antioxidants present in the grape skin and seeds (Yilmaz and Toledo, 
2004); these compounds are flavan-3-ols which are colorless and include epicatechin and 
catechin.  The colored compounds are flavanones such as quercetin and red and blue 
anthocyanins (Shi et al, 2003). Anthocyanins are responsible for the blue, purple and red 
color of many plant tissues including grapes (Prior and Wu, 2006).  Common 
anthocyanin compounds in grapes are glucosides, caffeoylglucosides, diglucosides of 
cyanidins, delphinidin, peonidin, petunidin, and malvidin (Wang et al., 2003). The major 
stilbene derivative found in grapes is resveratrol (Iriti and Faoro, 2006), which we used as 
our positive control.  The anthocyanin and flavonoid of the Rubaiyat grape extract in our 
study was determined to be approximately 66 and 620 µg/mL, respectively.  However, 
the amount of these active compounds present in grapes depends on several factors 
including the cultivar, year of production (climate), site of production (geographic origin, 
soil quality, and fertilization), and degree of maturation (Shi et al., 2003).  
In our study we compared the effects of different doses of Rubaiyat grape extract 
to that of resveratrol in inhibiting human MCF-7 cell proliferation. We have found that 
higher doses of the extract are needed to inhibit MCF-7 proliferation in comparison to 
resveratrol. This is understandable as the concentration of the Rubaiyat grape ext ct used 
in the study was based on the total phenolic content of the grape extract. The identity of 
compounds in the extract and the molecular weights are unknown and so the Rubaiyat 
grape extract concentration was based on the total phenolic compounds equivalent to 
resveratrol.  When comparing overall concentration with treatment with time, we found 
statistical significance (P = 0.0078) regardless of treatment type.   
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 In our study, we used 11.25 µg/mL (50 µM) as the lowest and 228 µg/mL (1000 
µM) as the highest concentrations of resveratrol in order to see dose-dependent effects. 
We observed that inhibition of cellular proliferation by resveratrol started at 11.25 µg/mL 
(50 µM) but marked inhibition was observed at 45 µg/mL (200 µM) and no additional 
benefit with 228 µg/mL (1000 µM).  Similar to our study, some of the studies 
investigating anti-cancer properties of resveratrol have demonstrated inhibitory effects at 
50 uM (Kim et al., 2004; Murias et al., 2008; Pozo-Guisado et al., 2002). For example, 
MCF-7 breast cancer cells treated with 50 µM resveratrol showed an accumulation of 
cells in the early phases of the cell cycle as compared to the controls which showed an 
increased amount of cells in the late and final phases of the cell cycle  (Kim et al., 2004).  
Although 11.25 µg/mL (50 uM) was shown to be effective, different 
concentrations of resveratrol have also been used in other studies. Murias et al. (2008) 
found that an analogue of resveratrol (3,3’,4,4’,5,5’-hexahydroxystilbene) was shown to 
inhibit cell growth in three breast cancer cell lines in a concentration-depen nt manner. 
The three cell lines exhibited a concentration-dependent loss of mitochondrial potential 
while 50 µM of the analogue caused a time-dependent loss. In two of the cell lines (ZR-
75-1 and T47D), caspase-3 and caspase-9 were detected while all three caspases 
(caspases -3, -8, and -9) showed activation in MDA-MB-231 cells. The results of thi
study demonstrated that apoptosis induced by the resveratrol analogue was dose-
dependent and mitochondrial in origin as shown by the dissipation of mitochondrial 
membrane potential that is closely followed by caspase-9 activation (Murias et al, 2008). 
 It is interesting to note that the inhibition of cell proliferation may be affcted by 
the type of isomer of resveratrol as shown by Basly and colleagues (2000). Their findings 
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demonstrated that the (Z)-isomer of resveratrol was less effective than the (E)-isomer on 
the inhibition of cellular proliferation in both MCF-7 and MVLN cell lines.  Although we 
did not use specific isomers of resveratrol and Rubaiyat grape extract, there wer  still 
significant changes observed in cell proliferation that were concentratio -dependent as 
seen in the literature (Basly et al., 2000, Murias et al., 2008).  Anti-carcinogenic effects 
of the isomers of phenolic compounds isolated from Rubaiyat grapes needs to be 
explored. 
Since our study used total phenolic extract, we cannot identify which of the 
phenolic compound(s) is responsible for the anti-carcinogenic effect of the Rubaiyat 
grape extract. The majority of the studies on grape polyphenols, except for studies on 
resveratrol, have utilized extracts of unknown composition. Red wine polyphenols have 
been shown to decrease in vitro breast cancer cell proliferation (Damianaki et al., 2000).  
Hakimuddin and colleagues (2004) examined the anti-proliferative activity of three 
different structural classes of flavonoids from wine on breast cancer cell lines, MCF-10A 
and MCF-7, and one normal human mammary epithelial cell line (HMEC).  HMECs 
were most sensitive to the inhibition of the flavonoids as compared to MCF-10A and 
MCF-7 cell lines.  The less hydrophobic fraction (the crude fraction) of the wine showed 
similar inhibitory effects on all three cell lines while the more hydrophobic fraction 
showed the most inhibition of MCF-7 cancer cell line proliferation but not the other two 
cell lines.  The authors suggest that these results may be attributed to flavonoid fractions 
and growth inhibition is highly dependent on flavonoid concentration. Another study 
(Faria et al., 2006) evaluated the effects of procyanidin fractions on MCF-7 human breast 
carcinoma cells.  Catechin fractions (30 and 60 µg/mL) caused a decrease in cell 
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viability, inhibited cell proliferation of MCF-7 cells, and exhibited higher antioxidant 
activity.  The authors suggest that the antioxidant activity of procyanidins may be partly 
responsible for the effect on cell proliferation (Faria et al., 2006). Singletary t l. (2007) 
examined the effects of anthocyanin-rich extract from Concord grapes and anthocyin 
delphinidin on human breast epithelial cells with DNA damage from an environmental 
carcinogen, benzo[a]pyrene (BP).  Concord grape extract (CGE) inhibited BP-induced 
DNA adduct formation in the MCF-10F cell line.  These findings indicate that in 
chemically induced breast carcinogenesis, CGE and select constituent anthocy ins may 
be considered as potential blocking agents (Singletary et al., 2007).  Overall, the findings 
of these studies indicate that several components in grapes may exhibit anti-carci ogenic 
properties.   
In addition to the inhibition of cellular proliferation, we also investigated the 
apoptotic effects of Rubaiyat grape extract and resveratrol. Cells were treat d with 
different concentrations of Rubaiyat grape extract or resveratrol for 48 or 72 hours. The 
treatment was considered to induce apoptosis if cells were far less numerous and 
misshapen, smaller in size, and possibly indicating membrane blebbing. Grape extract 
and resveratrol treatment showed similar apoptotic results at their highest treatment 
concentration (228 µg/mL).  Rubaiyat grape extract at 228 µg/mL showed the most 
marked induction of apoptosis on human MCF-7 breast cancer cells compared to the 
control.  Resveratrol-treated cells showed these same characteristics in a dose-dependent 
manner and were observed starting at the lowest concentration (11.25 µg/mL= 50 µM 
concentration) and were most marked at 228 µg/mL (1000 µM) concentration. Apoptosis 
induction was most prominent at 72 hours for both treatments in comparison to 48 hours.  
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Our findings indicate that apoptosis induction is both concentration- and time-dependent 
with the highest concentration of each treatment showing most prominent apoptotic 
characteristics.   However, all these data analyses need to be interpreted with caution as 
apoptosis visualization was done using the naked eye and not by a quantitative method.   
The mechanism by which resveratrol and Rubaiyat grape extract exert anti-
carcinogenic effects is not clear at this time. Literature reports that growth suppression by 
resveratrol is the result of mid to late cell cycle arrest (Joe et al., 2002) and modulation of 
the apoptosis cascade (up-regulation of proapoptotic proteins, down-regulation of 
antiapoptotic proteins, and activation of caspase-3) (Nakagawa et al., 2001). Additionally, 
exposure of MCF-7 human breast cancer cells to resveratrol for 48 hours resulted in a 
dose-dependent cell cycle arrest and apoptosis (Kim et al., 2004). It was also observed 
that Bcl-2 protein content, a pro-apoptotic protein, is inversely proportional to the dose of 
resveratrol (Pozo-Guisado et al., 2005), and resveratrol was unable to induce caspas-3 
and caspase-8 activity, pro-apoptotic enzymes, in the MCF-7 breast cancer cell line 
(Pozo-Guisado et al., 2005), at concentrations similar to the ones used in our study.   
We also examined the effects of different concentrations of resveratrol and 
Rubaiyat grape extract on the gene expression of anti- and pro-apoptotic markers, Bcl-2 
and Bax, respectively. Rubaiyat grape extract treatment starting at 11.25 µg/mL and only 
45 µg/mL of resveratrol caused a significant reduction of Bcl-2 gene expression. Jourdain 
and Martinou (2009) reported that the Bcl-2 family is pro-apoptotic proteins which 
permeabilize the mitochondria during apoptosis by integrating and conveying death 
signals to the mitochondria in order to cause the release of other proteins and enzymes to 
continue with the apoptotic process.  These proteins act closely together signaling o e 
 63
another in a cascade to promote the apoptosis process (Jourdain and Martinou, 2009 and 
Tsujimoto, 2003).  Similar studies determined that induction of cell death by resveratrol 
was shown to be associated to Bcl-2 phosphorylation (Tinhofer et al., 2001), Bax 
mitochondrial translocation (Mahyar-Roemer, Kohler, and Roemer, 2002), and inhibition 
of AKT and FAK activity (Brownson et al., 2002).  Additionally, reduction of Bcl-2 gene 
expression was similar to that observed by Mantena et al (2006) with grape seed 
procyanidins treatment of mouse metastatic breast cancer cell line (4T1).   
Both resveratrol and Rubaiyat grape extract treatments had no significant effect 
on pro-apoptotic Bax expression. We do not know the reason why we did not see 
treatment effects on Bax gene expression since we observed some changes racteristic 
of apoptosis. 
The concentrations of resveratrol used in our study were similar to those used in 
other studies (Joe et al., 2002, Nakagawa et al., 2001, Kim et al., 2004, Pozo-Guisado et 
al., 2005). Our results on the effects of resveratrol on inhibition of cellular proliferation 
(Joe et al., 2002, Nakagawa et al., 2001, Kim et al., 2004, Pozo-Guisado et al., 2005) and 
apoptosis induction (Kim et al., 2004, Nakagawa et al., 2001, Pozo-Guisado et al., 2005) 
were similar to those of other investigators   However, our findings on the gene 
expression of Bax and Bcl-2 genes were different from others.  Other studies show 
increased expression of Bax and decreased expression of Bcl-2 with increasing 
concentrations of resveratrol (Kim et al., 2004, Nakagawa et al., 2001, Pozo-Guisado et 
al., 2005).  We found that resveratrol had no significant effect on pro-apoptotic Bax gene 
expression and anti-apoptotic Bcl-2 gene expression was only significantly decreas d at 
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the highest concentration (45 µg/mL which is equivalent to 200 µM) of resveratrol 
treatment. 
In summary, Rubaiyat grape extract inhibited cell proliferation and induced 
apoptosis in the MCF-7 cell line.  Since other components are present in the Rubaiyat 
grape extract, higher concentrations of the extract were needed to inhibit cell proliferation 
and induce apoptosis in this cell line.  The anti-carcinogenic property of the Rubaiyat 
grape extract may be attributed in part to the inhibition of Bcl-2 but not Bax.  However, 
these are the only genes that were examined and other genes might be affected more by 
Rubaiyat grape extract.   
  
Recommendations for future studies     
Further exploration of other apoptotic markers is warranted in order to better 
understand how polyphenols affect apoptosis in human MCF-7 breast cancer cells.  One 
step further is to assess the effects of the Rubaiyat grape extract in an anim l model.  For 
example, Mantena et al. (2006) gave immunocompetent Balb/c mice a diet consisting of 
0.2% and 0.5% w/w grape seed procyanidins (GSPs).  Dietary GSPs significantly 
inhibited the growth of subcutaneous tumors and increased survival rate in immune 
competent Balb/c mice, inoculated with 4T1 breast cancer cells.  GSP also inhibited 
metastasis of the 4T1 cells from the primary tumor site to the lungs, decreased expression 
of antiapoptotic Bcl-2, increased Bax, cytochrome c, and Apaf-1 expression as well  
activate caspase-3 in the tumors compared to control mice (Mantena et al., 2006).  
Whether Rubaiyat grape extract exerts similar effects needs to be explored.      
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 It may also be possible in future studies to better understand the use of resveratrol 
and grape extracts in the reduction of estrogen-related breast cancers.  I  vitro, resveratrol 
was shown to inhibit other known key regulators of cell proliferation such as PKC 
(Stewart et al., 1999), ribonucleotide reductase therefore interfering with DNA synthesis 
in proliferating cancer cells (Fontecave et al., 1998), and both the activity and 
transcription of COX2 (Subbaramaiah et al., 1998).  These are other important regulators 
of cellular proliferation that warrant further studies using resveratrol and Rubaiyat grape 
extract in human MCF-7 cells to better understand the mechanism behind inhibition of 
proliferation and induction of apoptosis.  
Also, further research in the area of Rubaiyat grape extract and resveratrol is 
needed to identify a safe dosage to consume on a regular basis for supplementation.  
Moreover, the amount of whole grape that needs to be consumed for anti-cancer effects 
needs to also be explored.  The findings from this study are to be taken with caution as 
they do not indicate a safe dosage of extract or resveratrol or amount of whole grape to be 
consumed.  More in vitro and in vivo studies need to be conducted in order to determine 
the proper dosage or consumption recommendations in which to see beneficial effects.
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